Please login to the form below
Phillip Frost to remain chair of Teva Pharmaceutical
Re-elected by board for at least three more years
Dr Phillip Frost has been re-elected as chair of Teva Pharmaceutical.
The Israel-based firm's board of directors unanimously voted for Dr Frost to remain in the position for at least three more years, subject to shareholder approval.
He has served as chair since March 2010, having previously been vice chair from January 2006.
Prior to his time at Teva, he was chair and CEO of IVAX Xorporate from 1987 to 2006.
The board's vice chair, Professor Moshe Many, said: “Dr Phillip Frost has the Board's full support. We would continue to benefit from his vision and guidance.
“We look forward to the progress of the company under the governance of the Board and the leadership of Teva's President and CEO Dr. Jeremy Levin.”
Dr Frost's continuation provides Teva with some stability as former senior vice president of strategy at Bristol-Myers Squibb, Jeremy Levin, begins his tenure as the company's CEO and president.
The company has also recently appointed genetics expert Dr Michael Hayden as its first president of global R&D and chief scientific officer.
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
SENIOR MEDICAL WRITER
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
- Sinovac’s COVID-19 vaccine appears safe in older adults
- STEM Healthcare founder Rob Wood secures a 25% stake in performance-io
- Pfizer/BioNTech and Moderna increase COVID-19 vaccine supplies to the EU
- AZ/Oxford University vaccine shows 82.4% efficacy with extended dosing schedule
- AZ sells stake in Moderna for around $1.2bn
- UK study finds Pfizer/BioNTech, AZ/Oxford vaccines reduce severe COVID-19 in older people
- Syneos Health Communications announces senior hires to Europe-based team
- First shipments of AZ/Oxford COVID-19 vaccine sent through COVAX
- Merck & Co to help produce J&J’s COVID-19 vaccine in the US
- AbbVie buys exclusive right to acquire Mitokinin’s Parkinson’s asset
- Andi Goes – the children’s book that helps detect early signs of dyslexia
- UK study finds Pfizer/BioNTech, AZ/Oxford vaccines reduce severe COVID-19 in older people
PMHub
KVA Digital
KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...
Latest intelligence
- Good design saves lives
- Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
- Why you must understand the pricing of patient recruitment companies
- Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
- A cultural shift in clinical research
- Research organisations across the board are experimenting with new technologies...
Quick links
Infographics
